Identification of hepatocellular carcinoma patients who will benefit from 18F-fludeoxyglucose-positron emission tomography imaging for disease staging and determination of optimal treatment strategies

被引：0
|
作者：
Kawamura, Etsushi [1 ]
Shiomi, Susumu [2 ]
Kotani, Kohei [2 ]
Hagihara, Atsushi [1 ]
Fujii, Hideki [1 ]
Uchida, Sawako K. [1 ]
Iwai, Shuji [1 ]
Morikawa, Hiroyasu [1 ]
Kawabe, Joji [2 ]
Enomoto, Masaru [1 ]
Murakami, Yoshiki [1 ]
Tamori, Akihiro [1 ]
Kawada, Norifumi [1 ]
机构：
[1] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka 558, Japan
[2] Osaka City Univ, Grad Sch Med, Dept Nucl Med, Osaka 558, Japan
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1542
引用
收藏
页码：953A / 954A
页数：2
相关论文
共 50 条
  • [1] Use of 18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography for Patient Management and Outcome in Oropharyngeal Squamous Cell Carcinoma
    Taghipour, Mehdi
    Sheikhbahaei, Sara
    Marashdeh, Wael
    Solnes, Lilja
    Kiess, Anna
    Subramaniam, Rathan M.
    [J]. JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2016, 142 (01) : 79 - 85
  • [2] Role of [18F] fludeoxyglucose positron emission tomography in the selection of liver transplantation candidates in patients with hepatocellular carcinoma
    Ye, Yu-Fu
    Wang, Wei
    Wang, Ting
    Yu, Jun
    Geng, Lei
    Yu, Song-Feng
    Yan, Sheng
    Zheng, Shu-Sen
    [J]. HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2017, 16 (03) : 257 - 263
  • [3] Role of [18F] fludeoxyglucose positron emission tomography in the selection of liver transplantation candidates in patients with hepatocellular carcinoma
    Yu-Fu Ye
    Wei Wang
    Ting Wang
    Jun Yu
    Lei Geng
    Song-Feng Yu
    Sheng Yan
    Shu-Sen Zheng
    [J]. Hepatobiliary & Pancreatic Diseases International, 2017, 16 (03) : 257 - 263
  • [4] 18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography and Laparoscopy for Staging of Locally Advanced Gastric Cancer A Multicenter Prospective Dutch Cohort Study (PLASTIC)
    Gertsen, Emma C.
    Brenkman, Hylke J. F.
    van Hillegersberg, Richard
    van Sandick, Johanna W.
    Henegouwen, Mark I. van Berge
    Gisbertz, Suzanne S.
    Luyer, Misha D. P.
    Nieuwenhuijzen, Grard A. P.
    van Lanschot, Jan J. B.
    Lagarde, Sjoerd M.
    Wijnhoven, Bas P. L.
    de Steur, Wobbe O.
    Hartgrink, Henk H.
    Stoot, Jan H. M. B.
    Hulsewe, Karel W. E.
    Bilgen, Ernst J. Spillenaar
    van Det, Marc J.
    Kouwenhoven, Ewout A.
    van der Peet, Donald L.
    Daams, Freek
    van Grieken, Nicole C. T.
    Heisterkamp, Joos
    van Etten, Boudewijn
    van den Berg, Jan Willem
    Pierie, Jean Pierre
    Eker, Hasan H.
    Thijssen, Annemieke Y.
    Belt, Eric J. T.
    van Duijvendijk, Peter
    Wassenaar, Eelco
    van Laarhoven, Hanneke W. M.
    Wevers, Kevin P.
    Hol, Lieke
    Wessels, Frank J.
    Mohammad, Nadia Haj
    van der Meulen, Miriam P.
    Frederix, Geert W. J.
    Vegt, Erik
    Siersema, Peter D.
    Ruurda, Jelle P.
    [J]. JAMA SURGERY, 2021, 156 (12) : E1 - E9
  • [5] Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma
    Chalaye, Julia
    Costentin, Charlotte E.
    Luciani, Alain
    Amaddeo, Giuliana
    Ganne-Carrie, Nathalie
    Baranes, Laurence
    Allaire, Manon
    Calderaro, Julien
    Azoulay, Daniel
    Nahon, Pierre
    Seror, Olivier
    Mallat, Ariane
    Soussan, Michael
    Duvoux, Christophe
    Itti, Emmanuel
    Nault, Jean Charles
    [J]. JOURNAL OF HEPATOLOGY, 2018, 69 (02) : 336 - 344
  • [6] An Intensive 18F-Fludeoxyglucose-Positron Emission Tomography With Computed Tomography-Based Strategy of Follow-Up in Patients Treated for Head and Neck Squamous Cell Carcinoma Who Are Clinically Asymptomatic
    Leclere, Jean-Christophe
    Clement, Camille
    Le Pennec, Romain
    Maheo, Clementine
    Gujral, Dorothy M.
    Schick, Ulrike
    Le Gal, Gregoire
    Marianowski, Remi
    Salaun, Pierre-Yves
    Abgral, Ronan
    [J]. JAMA NETWORK OPEN, 2023, 6 (08) : e2326654
  • [7] Response to: Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma
    Noordzij, Walter
    de Jong, Koert P.
    de Meijer, Vincent E.
    [J]. JOURNAL OF HEPATOLOGY, 2018, 69 (02) : 554 - 555
  • [8] Reply to: "Response to: Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma''
    Chalaye, Julia
    Costentin, Charlotte E.
    Luciani, Alain
    Nault, Jean-Charles
    [J]. JOURNAL OF HEPATOLOGY, 2018, 69 (02) : 555 - 556
  • [9] The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma
    Wudel, LJ
    Delbeke, D
    Morris, D
    Rice, M
    Washington, MK
    Shyr, Y
    Pinson, CW
    Chapman, WC
    [J]. AMERICAN SURGEON, 2003, 69 (02) : 117 - 124
  • [10] 18F-fluorodeoxyglucose positron emission tomography for monitoring response to sorafenib treatment in patients with hepatocellular carcinoma
    Siemerink, Ester J. M.
    Mulder, Nanno H.
    Brouwers, Adrienne H.
    Hospers, Geke A. P.
    [J]. ONCOLOGIST, 2008, 13 (06): : 734 - 735
12345